Patent Yard Sign in
Expired Canadian patentCanada

Device for filtering blood in a vessel with helical elements

CA 2512232 C · Owner: Cordis Corporation · Inventors: Niermann, Volker

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A device for capturing an embolus within a vessel of a patient's body has at least one helix made of a mesh material. The at least one helix has a plurality of turns helically arranged around a longitudinal axis. The mesh material has a plurality of pores therein and the pores have a size >= 120 µm. The at least one helix includes a plurality of panels wherein the panels are movable from a collapsed state to an expanded state when placed within a vessel. The mesh material is made of a self expanding material such as nickel titanium in one embodiment. In another embodiment the device has a double helix arrangement.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 12, 2005 and granted December 10, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 12, 2025.
  • Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 12, 2005
GrantedDecember 10, 2013
Term endedJuly 12, 2025
Patent numberCA 2512232 C
Classification (IPC)A61F2/01 +1 more

Timeline

Timeline From CIPO dates

2006200820102012201420162018202020222024Application filedJuly 12, 2005Patent grantedDec 10, 2013Term endedJuly 12, 2025

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.